Long-term left-ventricular-assist-device therapy is here to stay

Nature Clinical Practice Cardiovascular Medicine

Volumn 5, Issue 2, 2008, Pages 60-61

  Yacoub, Magdi H ^a,b   Miller, Leslie W ^c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b Harefield Heart Science Centre   (United Kingdom)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLENBUTEROL; CLOPIDOGREL;

CLINICAL TRIAL; CONVALESCENCE; DEATH; DISEASE SEVERITY; EQUIPMENT DESIGN; EUROPE; EVIDENCE BASED MEDICINE; FOLLOW UP; HEART ASSIST DEVICE; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; INCIDENCE; INTERNATIONAL NORMALIZED RATIO; LIFE EXPECTANCY; MEDICAL DECISION MAKING; MEDICAL RESEARCH; MULTIPLE ORGAN FAILURE; ORGAN DONOR; PATIENT SELECTION; POSTOPERATIVE INFECTION; POSTOPERATIVE THROMBOSIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROSTHESIS FAILURE; QUALITY OF LIFE; REVIEW; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT INDICATION; TREATMENT OUTCOME; UNITED STATES;

HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; PATIENT SELECTION; PROSTHESIS DESIGN; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 38649113926     PISSN: 17434297     EISSN: 17434300     Source Type: Journal    
DOI: 10.1038/ncpcardio1067     Document Type: Review

References (10)

1. American Heart Association (2006) Heart disease and stroke statistics - 2006 update. [http://www.americanheart.org/downloadable/heart/ 1136308648540Statupdate2006.pdf] (accessed 12 September 2007)
2. Maisel AS et al. (2006) Cardiac biomarkers: A contemporary status report. Nat Clin Pract Cardiovasc Med 3:24-34
3. Birks EJ et al. (2004) Incidence and clinical management of life-threatening left ventricular assist device failure. J Heart Lung Transplant 23: 964-969
4. Thohan V et al. (2005) Cellular and hemodynamic responses of failing myocardium to continuous flow mechanical circulatory support using the DeBakey-Noon left ventricular assist device: A comparative analysis with pulsatile-type devices. J Heart Lung Transplant 24: 566-575
5. Miller LW et al. for the HeartMate II Clinical Investigators (2007) Use of a continuous flow device in patients awaiting heart transplantation. N Engl J Med 357: 885-896
6. Frazier OH and Myers TJ (1999) Left ventricular assist system as a bridge to myocardial recovery. Ann Thorac Surg 68: 734-741
7. Yacoub MH (2001) A novel strategy to maximize the efficacy of left ventricular assist devices as a bridge to recovery. Eur Heart J 22: 534-540
8. Birks EJ et al. (2006) Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med 355: 1873-1884
9. Rose EA et al. for the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group (2001) Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 345: 1435-1443
10. Weinstein MC and Fineberg HV (1980) Clinical Decision Analysis. Oxford: WB Saunders Co. Ltd